These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36638064)

  • 1. Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?
    VandenBroek MM; Skebo SI; Ormiston ML
    Expert Opin Ther Targets; 2022 Dec; 26(12):1027-1030. PubMed ID: 36638064
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.
    Soon E; Crosby A; Southwood M; Yang P; Tajsic T; Toshner M; Appleby S; Shanahan CM; Bloch KD; Pepke-Zaba J; Upton P; Morrell NW
    Am J Respir Crit Care Med; 2015 Oct; 192(7):859-72. PubMed ID: 26073741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial
    Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
    Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW
    Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue.
    Sobolewski A; Rudarakanchana N; Upton PD; Yang J; Crilley TK; Trembath RC; Morrell NW
    Hum Mol Genet; 2008 Oct; 17(20):3180-90. PubMed ID: 18647753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II.
    Burton VJ; Holmes AM; Ciuclan LI; Robinson A; Roger JS; Jarai G; Pearce AC; Budd DC
    Blood; 2011 Oct; 118(17):4750-8. PubMed ID: 21900197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension.
    Rudarakanchana N; Flanagan JA; Chen H; Upton PD; Machado R; Patel D; Trembath RC; Morrell NW
    Hum Mol Genet; 2002 Jun; 11(13):1517-25. PubMed ID: 12045205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
    Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
    Upton PD; Morrell NW
    Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
    Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
    Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
    Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of bone morphogenetic protein receptor type II mRNA from ascitic and nonascitic commercial broilers.
    Cisar CR; Balog JM; Anthony NB; Donoghue AM
    Poult Sci; 2003 Oct; 82(10):1494-9. PubMed ID: 14601724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
    Nickel NP; Spiekerkoetter E; Gu M; Li CG; Li H; Kaschwich M; Diebold I; Hennigs JK; Kim KY; Miyagawa K; Wang L; Cao A; Sa S; Jiang X; Stockstill RW; Nicolls MR; Zamanian RT; Bland RD; Rabinovitch M
    Am J Respir Crit Care Med; 2015 Jun; 191(11):1273-86. PubMed ID: 25853696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the interactions among BMPR-2, ALK-1 and 5-HTT genes in the pathophysiology of HAPE.
    Ali Z; Waseem M; Kumar R; Pandey P; Mohammad G; Qadar Pasha MA
    Gene; 2016 Aug; 588(2):163-72. PubMed ID: 27196063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.
    Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC
    Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia.
    Beppu H; Ichinose F; Kawai N; Jones RC; Yu PB; Zapol WM; Miyazono K; Li E; Bloch KD
    Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1241-7. PubMed ID: 15286002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.